Hillsdale Investment Management Inc. Maintains Position in Chemed Corp. (CHE)
Hillsdale Investment Management Inc. held its stake in shares of Chemed Corp. (NYSE:CHE) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,800 shares of the company’s stock at the end of the 2nd quarter. Hillsdale Investment Management Inc.’s holdings in Chemed Corp. were worth $1,391,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also made changes to their positions in the company. Chicago Equity Partners LLC increased its stake in Chemed Corp. by 88.5% during the 2nd quarter. Chicago Equity Partners LLC now owns 17,530 shares of the company’s stock worth $3,585,000 after buying an additional 8,230 shares during the period. American Century Companies Inc. acquired a new position in Chemed Corp. during the 2nd quarter worth approximately $4,201,000. Citadel Advisors LLC grew its holdings in Chemed Corp. by 195.4% during the 1st quarter. Citadel Advisors LLC now owns 4,558 shares of the company’s stock worth $833,000 after acquiring an additional 3,015 shares in the last quarter. Legal & General Group Plc grew its holdings in Chemed Corp. by 9.5% during the 2nd quarter. Legal & General Group Plc now owns 31,177 shares of the company’s stock worth $6,378,000 after acquiring an additional 2,709 shares in the last quarter. Finally, Vanguard Group Inc. grew its holdings in Chemed Corp. by 7.5% during the 1st quarter. Vanguard Group Inc. now owns 1,795,773 shares of the company’s stock worth $328,070,000 after acquiring an additional 125,018 shares in the last quarter. 96.96% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY NOTICE: “Hillsdale Investment Management Inc. Maintains Position in Chemed Corp. (CHE)” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was stolen and republished in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/28/hillsdale-investment-management-inc-maintains-position-in-chemed-corp-che.html.
Chemed Corp. (CHE) traded down 0.018% on Thursday, reaching $197.065. 5,644 shares of the company’s stock traded hands. The firm has a market capitalization of $3.15 billion, a P/E ratio of 48.887 and a beta of 1.14. Chemed Corp. has a 52 week low of $132.92 and a 52 week high of $216.01. The stock has a 50-day moving average of $193.25 and a 200 day moving average of $196.09.
Chemed Corp. (NYSE:CHE) last posted its quarterly earnings data on Tuesday, July 25th. The company reported $2.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.89 by $0.26. The company had revenue of $415.06 million for the quarter, compared to analyst estimates of $407.56 million. Chemed Corp. had a net margin of 4.16% and a return on equity of 26.18%. The business’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the firm posted $1.80 earnings per share. On average, equities analysts expect that Chemed Corp. will post $8.21 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, September 1st. Stockholders of record on Monday, August 14th were paid a dividend of $0.28 per share. The ex-dividend date was Thursday, August 10th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 0.58%. This is a positive change from Chemed Corp.’s previous quarterly dividend of $0.26. Chemed Corp.’s dividend payout ratio (DPR) is currently 28.07%.
Several research analysts have commented on the stock. Royal Bank Of Canada reiterated a “hold” rating and set a $208.00 price target on shares of Chemed Corp. in a report on Wednesday, July 5th. BidaskClub cut shares of Chemed Corp. from a “strong-buy” rating to a “buy” rating in a report on Thursday, June 22nd. Oppenheimer Holdings, Inc. boosted their price target on shares of Chemed Corp. from $200.00 to $220.00 and gave the stock an “outperform” rating in a report on Thursday, July 27th. TheStreet cut shares of Chemed Corp. from a “b+” rating to a “c+” rating in a report on Tuesday, July 25th. Finally, Zacks Investment Research upgraded shares of Chemed Corp. from a “hold” rating to a “buy” rating and set a $226.00 price target for the company in a report on Friday, July 28th. Three equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $215.00.
In other news, insider Kevin J. Mcnamara sold 15,000 shares of Chemed Corp. stock in a transaction that occurred on Friday, July 28th. The shares were sold at an average price of $201.16, for a total transaction of $3,017,400.00. Following the sale, the insider now owns 173,801 shares in the company, valued at $34,961,809.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Spencer S. Lee sold 1,000 shares of Chemed Corp. stock in a transaction that occurred on Friday, September 1st. The shares were sold at an average price of $197.46, for a total transaction of $197,460.00. Following the sale, the insider now owns 37,809 shares in the company, valued at approximately $7,465,765.14. The disclosure for this sale can be found here. Company insiders own 5.32% of the company’s stock.
About Chemed Corp.
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corp. (NYSE:CHE).
Receive News & Stock Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related stocks with our FREE daily email newsletter.